Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine Versus Dexmedetomidine as Adjuvants to Bupivacaine in Ultrasound Guided Bilateral Superficial Cervical Plexus Block in Patients Undergoing Thyroidectomy: a Prospective Randomized Controlled Study

NCT07838831 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT07838831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07838831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine Versus Dexmedetomidine as Adjuvants to Bupivacaine in Ultrasound Guided Bilateral Superficial Cervical Plexus Block in Patients Undergoing Thyroidectomy: a Prospective Randomized Controlled Study
Lead sponsor
Tanta University
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2025
Completion date
August 30, 2026
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bupivacaine, dexmedetomidine, thyroidectomy